Bisoprolol Equivalent Dose for Metoprolol Succinate in AFib

Introduction to Bisoprolol Dosing

The American College of Cardiology recommends that for a patient with atrial fibrillation taking 75 mg metoprolol succinate daily, the equivalent bisoprolol dose is approximately 3.75 mg daily, which should be rounded to either 2.5 mg or 5 mg daily based on clinical response and tolerability 1, 2

Metoprolol succinate 75 mg daily falls between the typical starting dose (50 mg) and mid-range therapeutic doses (50-400 mg daily) for AFib rate control, with the American College of Cardiology and Circulation guidelines supporting this range 1, 2
Bisoprolol dosing range for AFib is 2.5-10 mg daily, with most patients responding to 2.5-5 mg daily, as recommended by the American College of Cardiology and Circulation 1, 2
The approximate potency ratio is 1:5 to 1:10 (bisoprolol:metoprolol), meaning bisoprolol is roughly 5-10 times more potent than metoprolol on a milligram-per-milligram basis, according to Circulation 3

The American College of Cardiology and Circulation recommend starting with bisoprolol 2.5 mg daily as the initial equivalent dose, representing a conservative conversion that minimizes risk of excessive bradycardia or hypotension 1, 2
The longer half-life of bisoprolol (9-12 hours) compared to metoprolol succinate (3-7 hours) provides more consistent 24-hour coverage, as noted by the American College of Cardiology and Circulation 1, 2

The American College of Cardiology and Circulation suggest assessing resting heart rate (target <80 bpm for symptomatic patients, <110 bpm may be acceptable if asymptomatic with preserved LV function) after conversion 1, 2, 4
Blood pressure should be monitored, watching for hypotension, particularly systolic BP <90 mmHg, with guidelines from Praxis Medical Insights supporting this approach 5
Symptoms of bradycardia (dizziness, fatigue, syncope) should be assessed, according to Circulation 2

Bisoprolol has higher beta-1 selectivity, reducing the risk of bronchospasm in patients with mild reactive airway disease, as recommended by the American College of Cardiology and Circulation 1, 2
Bisoprolol has a longer half-life (9-12 hours vs 3-7 hours), providing more consistent rate control throughout the day, according to the American College of Cardiology and Circulation 1, 2
Once-daily dosing of bisoprolol improves medication adherence, as suggested by the American College of Cardiology and Circulation 1, 2

A 1:1 dose conversion should not be used, as this would result in severe bradycardia and hypotension, with the American College of Cardiology, Circulation, and Praxis Medical Insights warning against this approach 1, 2, 3
Bisoprolol should be avoided in decompensated heart failure, ensuring the patient is euvolemic before switching, as recommended by Circulation and Praxis Medical Insights 3, 4
Bisoprolol should not be combined with other AV nodal blocking agents without careful monitoring, as this can cause profound bradycardia, according to Praxis Medical Insights 5
Bisoprolol should be avoided in pre-excited AFib (WPW syndrome with AFib), as beta-blockers may paradoxically accelerate ventricular response, with Praxis Medical Insights supporting this caution 4, 5
Renal function should be monitored, as dose adjustments may be needed in severe renal impairment, according to the American College of Cardiology and Circulation 1, 2